Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms
Zahra Kiasalari, Rana Heydarifard, Mohsen Khalili, et al.
Psychopharmacology (2017) Vol. 234, Iss. 12, pp. 1841-1852
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential
Javad Sharifi‐Rad, Cristina Quispe, Carla Marina Salgado Castillo, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 202
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
The bioactivity and applications of pomegranate peel extract: A review
Qiwen Xiang, Meifeng Li, Jiayu Wen, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 7
Closed Access | Times Cited: 71
Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis
Fakiha Firdaus, Mohd Faraz Zafeer, Ehraz Anis, et al.
Toxicology Reports (2018) Vol. 5, pp. 411-417
Open Access | Times Cited: 97
Ellagic acid in suppressing in vivo and in vitro oxidative stresses
Alam Zeb
Molecular and Cellular Biochemistry (2018) Vol. 448, Iss. 1-2, pp. 27-41
Closed Access | Times Cited: 96
Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review
Silvana Alfei, Federica Turrini, Silvia Catena, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111724-111724
Closed Access | Times Cited: 85
Neuroprotective effects of Ellagic acid against acrylamide-induced neurotoxicity in rats
Mehdi Goudarzi, Mohammad Amin Mombeini, Iman Fatemi, et al.
Neurological Research (2019) Vol. 41, Iss. 5, pp. 419-428
Closed Access | Times Cited: 80
Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damage
María Pascual, Maria Calvo‐Rodriguez, Lucı́a Núñez, et al.
IUBMB Life (2021) Vol. 73, Iss. 7, pp. 900-915
Open Access | Times Cited: 77
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 68
Ellagic Acid and Its Anti-Aging Effects on Central Nervous System
Heyu Zhu, Yuanmei Yan, Yi Jiang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10937-10937
Open Access | Times Cited: 42
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 25
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 12
Wine lees as functional ingredient to produce biscuits fortified with polyphenols and dietary fibre
Giusy Rita Caponio, Roberta Miolla, Mirco Vacca, et al.
LWT (2024) Vol. 198, pp. 115943-115943
Open Access | Times Cited: 9
Multi‐Targeting Phytochemicals for Alzheimer's Disease
R. Bhattacharya, Raghuraj Singh, Archna Panghal, et al.
Phytotherapy Research (2025)
Open Access | Times Cited: 1
Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease
Abhishek Jha, Shital S. Panchal, Apeksha Shah
Pharmacology Biochemistry and Behavior (2018) Vol. 175, pp. 33-46
Closed Access | Times Cited: 82
Ellagic acid protects against diabetes-associated behavioral deficits in rats: Possible involved mechanisms
Yaghoob Farbood, Masome Rashno, Shahab Ghaderi, et al.
Life Sciences (2019) Vol. 225, pp. 8-19
Closed Access | Times Cited: 62
Toll-like receptors in Alzheimer's disease
Sara Momtazmanesh, George Perry, Nima Rezaei
Journal of Neuroimmunology (2020) Vol. 348, pp. 577362-577362
Closed Access | Times Cited: 53
Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson’s disease: A review
Qianhui Wang, Benson O. A. Botchway, Yong Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113848-113848
Open Access | Times Cited: 29
Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment
Morteza Nazari-Serenjeh, Tourandokht Baluchnejadmojarad, Masoud Hatami-Morassa, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25564-e25564
Open Access | Times Cited: 7
Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress
Reihaneh Ghasemi-Tarie, Zahra Kiasalari, Marzieh Fakour, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 5, pp. 1337-1349
Closed Access | Times Cited: 23
Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway
Meghna Bains, Jaspreet Kaur, Ansab Akhtar, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175316-175316
Closed Access | Times Cited: 23
Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation
Mahmoud Khaleghi-Mehr, Alireza-Azizzadeh Delshad, Sepideh Shafie-Damavandi, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1127-1142
Closed Access | Times Cited: 15
Ellagic acid ameliorates arsenic-induced neuronal ferroptosis and cognitive impairment via Nrf2/GPX4 signaling pathway
Xiyue Yang, Fang Chu, Zhe Jiao, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 283, pp. 116833-116833
Closed Access | Times Cited: 6
Oral administration of ellagic acid mitigates perioperative neurocognitive disorders, hippocampal oxidative stress, and neuroinflammation in aged mice by restoring IGF-1 signaling
Fang Chen, Kai Lǚ, Ning Bai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top